These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3559264)

  • 1. Patients with bone marrow failure demonstrate decreased cutaneous reactivity to human C5a.
    Yancey KB; Bielory L; Wright R; Young N; Frank MM; Lawley TJ
    J Invest Dermatol; 1987 Apr; 88(4):388-92. PubMed ID: 3559264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of human C5a as a mediator of inflammation in normal human skin.
    Yancey KB; Hammer CH; Harvath L; Renfer L; Frank MM; Lawley TJ
    J Clin Invest; 1985 Feb; 75(2):486-95. PubMed ID: 2982914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory properties of human C5a and C5a des Arg/ in mast cell-depleted human skin.
    Swerlick RA; Yancey KB; Lawley TJ
    J Invest Dermatol; 1989 Sep; 93(3):417-22. PubMed ID: 2527912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A direct in vivo comparison of the inflammatory properties of human C5a and C5a des Arg in human skin.
    Swerlick RA; Yancey KB; Lawley TJ
    J Immunol; 1988 Apr; 140(7):2376-81. PubMed ID: 3351304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate inhibits the human C5a-induced skin response in patients with psoriasis.
    Ternowitz T; Bjerring P; Andersen PH; Schröder JM; Kragballe K
    J Invest Dermatol; 1987 Aug; 89(2):192-6. PubMed ID: 3598210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C5a as a mediator of cutaneous inflammation.
    Yancey KB; Swerlick RA; Lawley TJ
    Am J Dermatopathol; 1987 Apr; 9(2):138-43. PubMed ID: 3332749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wheal and flare responses to opioids in humans.
    Levy JH; Brister NW; Shearin A; Ziegler J; Hug CC; Adelson DM; Walker BF
    Anesthesiology; 1989 May; 70(5):756-60. PubMed ID: 2470272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast cells are not required for anaphylatoxin-induced ileal smooth muscle contraction.
    Stimler-Gerard NP; Galli SJ
    J Immunol; 1987 Mar; 138(6):1908-13. PubMed ID: 2434565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil recruitment by intradermally injected neutrophil attractant/activation protein-1.
    Leonard EJ; Yoshimura T; Tanaka S; Raffeld M
    J Invest Dermatol; 1991 May; 96(5):690-4. PubMed ID: 2022877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C5a receptors are detectable on mast cells in normal human skin and in psoriatic plaques but not in weal and flare reactions or in uticaria pigmentosa by immunohistochemistry.
    Werfel T; Oppermann M; Begemann G; Götze O; Zwirner J
    Arch Dermatol Res; 1997 Jan; 289(2):83-6. PubMed ID: 9049041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intradermal tests using vasomotor agents in allergic rhinitis].
    Milosević DN; Janosević LjB; Janosević SB
    Srp Arh Celok Lek; 2000; 128(11-12):357-62. PubMed ID: 11337913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of complement inactivation and IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticaria.
    Fagiolo U; Kricek F; Ruf C; Peserico A; Amadori A; Cancian M
    J Allergy Clin Immunol; 2000 Sep; 106(3):567-72. PubMed ID: 10984379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of terbutaline and bambuterol on immediate-type allergic skin responses and mediator release in human skin.
    Petersen LJ; Skov PS
    Inflamm Res; 2003 Sep; 52(9):372-7. PubMed ID: 14504664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wheal-and-flare responses to intradermally injected adenosine 5'-monophosphate, hypertonic saline, and histamine: comparison of atopic and nonatopic subjects.
    Djukanovic R; Finnerty JP; Holgate ST
    J Allergy Clin Immunol; 1989 Sep; 84(3):373-8. PubMed ID: 2506263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous responses to anticholinergics: evidence for muscarinic receptor subtype participation.
    Cavanah DK; Casale TB
    J Allergy Clin Immunol; 1991 May; 87(5):971-6. PubMed ID: 2026847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular inflammatory responses during immediate, developing, and established late-phase allergic cutaneous reactions: effects of cetirizine.
    Zweiman B; Atkins PC; Moskovitz A; von Allmen C; Ciliberti M; Grossman S
    J Allergy Clin Immunol; 1997 Sep; 100(3):341-7. PubMed ID: 9314346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the interaction of human C5a and C5a des Arg with human monocytes and neutrophils: flow cytometric and chemotaxis studies.
    Yancey KB; Lawley TJ; Dersookian M; Harvath L
    J Invest Dermatol; 1989 Feb; 92(2):184-9. PubMed ID: 2493055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity.
    Fick RB; Robbins RA; Squier SU; Schoderbek WE; Russ WD
    Pediatr Res; 1986 Dec; 20(12):1258-68. PubMed ID: 3540828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells.
    el-Lati SG; Dahinden CA; Church MK
    J Invest Dermatol; 1994 May; 102(5):803-6. PubMed ID: 7513741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and transfer of immediate cutaneous hypersensitivity in mice exposed to aerosolized antigen.
    Saloga J; Renz H; Lack G; Bradley KL; Greenstein JL; Larsen G; Gelfand EW
    J Clin Invest; 1993 Jan; 91(1):133-40. PubMed ID: 8423213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.